Medication Burden and Side Effect Perception Associated with Medication Non-adherence in Type 2 Diabetes: A Comparative Study Based on Multimorbidity Status
Sep 2026· Bangladesh Journal of Endocrinology and Metabolism· 0 citations· 17 references
TL;DR
The subjective perception of side effects showed a strong, statistically significant association with non-adherence, with patients perceiving side effects being four times more likely to report dose-skipping behaviors.
Abstract
Abstract
Medication non-adherence is a major challenge to optimal glycemic control in type 2 diabetes mellitus (T2DM), particularly when compounded by multimorbidity.
The aim of this study was to evaluate the relationships between objective medication burden (regimen complexity) and subjective side effect perception with self-reported medication non-adherence among patients with T2DM across a spectrum of chronic comorbidities.
A hospital-based, cross-sectional study was conducted among 213 patients with T2DM at a specialized tertiary care facility in Bangladesh. Purposive sampling was used to recruit participants from the outpatient department. Structured interviews recorded demographics, dosing frequencies, and six comorbidities.
The overall proportion of patients classified as non-adherent due to dose-skipping behaviors was 76.1% (
n
= 162). Subjective side effect perception escalated across the multimorbidity spectrum, rising from 31.6% in isolated T2DM to 83.3% in patients managing four concurrent comorbidities (
P
= 0.011). In the adjusted multivariate logistic regression model, standard demographic factors, the absolute number of daily medications (
P
= 0.707), and the total comorbidity score (
P
= 0.080) were not significantly associated with non-adherence. However, the subjective perception of side effects showed a strong, statistically significant association with non-adherence, with patients perceiving side effects being four times more likely to report dose-skipping behaviors (adjusted odds ratio = 4.08, 95% confidence interval: 1.98–8.40,
P
< 0.001).
Multimorbidity is cross-sectionally linked to higher regimen complexity and an increased reporting of drug side effects. Self-reported medication non-adherence is more strongly associated with the subjective experience of physical side effects than the objective count of chronic illnesses or prescribed pills.
Background: Medication adherence is a key determinant in the effective management of type 2 diabetes mellitus (T2DM). Poor adherence contributes to inadequate glycemic control, increased complications, and higher healthcare costs. This study aimed to assess patterns of medication adherence and associated factors among...
J. Sultana, M. Khan, M. Ali et al.· International Journal of Com...· 0 citations
Introduction: Medication adherence is an important factor in the effective management of Type 2 Diabetes Mellitus (T2DM), particularly among patients with comorbidities who may face more complex treatment regimens. This study aimed to determine the level of medication adherence and identify factors associated with adhe...
Erna Wanti, Siti Setianingsih, Silma Kaffah· International Journal of Hea...· 0 citations
Type 2 diabetes mellitus (T2DM) is a chronic metabolic condition with a profound impact on health-related quality of life (HRQoL). Poor adherence to medication, exercise prescriptions and self-care activities remains a significant barrier to glycaemic control and optimal patient outcomes. However, the multidimensio...
Kaushikkumar Patel, S. Diwan, Sweta Upadhyay· Apollo Medicine· 0 citations
Medication adherence is a key determinant of successful type 2 diabetes mellitus (T2DM) management, yet evidence regarding adherence levels and their correlation with patient characteristics in Indonesian primary healthcare remains limited. This study aimed to describe medication adherence levels and analyze the correl...
Riza Alfian, Muhammad Hafizh Abiyyu Fathin Fawwazi, Wirawan Adikusuma et al.· Jurnal Ilmiah Ibnu Sina· 0 citations
Background: Medication adherence rates across diseases that require immunosuppression, including autoimmune diseases, are low. While cost barriers affect medication adherence, it is unknown whether adherence rates related to cost barriers differ between medically immunosuppressed patients and similar patients with othe...
Samuel D. Good, Bryant R. England, E. Volkmann· Journal of Personalized Medi...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.